Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshitaka Narita

Showing results (1-10 of 276) with videos related to

Pageof 28
Sort By:
No Shinkei Geka. Neurological Surgery|February 16, 2022
[Next-Generation Sequencing Tests for Malignant Brain Tumors]Yoshitaka Narita
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 13, 2019
[Incidence of primary brain tumors]Yoshitaka Narita
Therapeutics and Clinical Risk Management|December 15, 2015
Bevacizumab for glioblastomaYoshitaka Narita
Japanese Journal of Clinical Oncology|April 16, 2013
Drug review: Safety and efficacy of bevacizumab for glioblastoma and other brain tumorsYoshitaka Narita
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 6, 2005
[Chemotherapy for brain metastases]Yoshitaka Narita
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 28, 2016
[Current Progress of Chemotheraphy for Glimoa]Yoshitaka Narita
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 28, 2005
[Mangement of brain metastases based on EBM]Yoshitaka Narita
Neurologia Medico-Chirurgica|July 26, 2013
Current knowledge and treatment strategies for grade II gliomasYoshitaka Narita
Brain and Nerve = Shinkei Kenkyu No Shinpo|May 19, 2022
[Glioblastoma That Does Not Improve with Standard Treatment: Poor Prognostic Factors and Future Perspectives]Yoshitaka Narita
Progress in Neurological Surgery|February 3, 2018
Chemotherapy of Diffuse Astrocytoma (WHO grade II) in AdultsYoshitaka Narita
Pageof 28

Showing results (1-10 of 276) with videos related to

Sort By:
Pageof 28
No Shinkei Geka. Neurological Surgery|February 16, 2022
[Next-Generation Sequencing Tests for Malignant Brain Tumors]Yoshitaka Narita
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 13, 2019
[Incidence of primary brain tumors]Yoshitaka Narita
Therapeutics and Clinical Risk Management|December 15, 2015
Bevacizumab for glioblastomaYoshitaka Narita
Japanese Journal of Clinical Oncology|April 16, 2013
Drug review: Safety and efficacy of bevacizumab for glioblastoma and other brain tumorsYoshitaka Narita
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 6, 2005
[Chemotherapy for brain metastases]Yoshitaka Narita
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 28, 2016
[Current Progress of Chemotheraphy for Glimoa]Yoshitaka Narita
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 28, 2005
[Mangement of brain metastases based on EBM]Yoshitaka Narita
Neurologia Medico-Chirurgica|July 26, 2013
Current knowledge and treatment strategies for grade II gliomasYoshitaka Narita
Brain and Nerve = Shinkei Kenkyu No Shinpo|May 19, 2022
[Glioblastoma That Does Not Improve with Standard Treatment: Poor Prognostic Factors and Future Perspectives]Yoshitaka Narita
Progress in Neurological Surgery|February 3, 2018
Chemotherapy of Diffuse Astrocytoma (WHO grade II) in AdultsYoshitaka Narita
Pageof 28